95435 ⎘
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups - , , or in which the condensed system contains two hetero rings
Sub-classes:CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS
#2MORPHIC FORMS OF MARIZOMIB AND USES THEREOF
#3Morphic forms of marizomib and uses thereof
#4Morphic forms of marizomib and uses thereof
#5Imidazo pyridine compounds
#6Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound
#7Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders
#8Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
#9Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
#10Materials for organic electroluminescent devices
#11Topoisomerase inhibitors
#12Furo[3. 2-B] pyrrol derivatives
#13Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
#14Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
#15Furo[3, 2-b] pyrrol derivatives
#165-lipoxygenase-activating protein (FLAP) inhibitors
#17Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
#18Analogs of Salinosporamide A
#195-lipoxygenase-activating protein (FLAP) inhibitors